Proprio is a medical technology company based in Seattle, Washington. We create the new way of seeing™ in surgery through a proprietary platform of artificial intelligence, computer vision, augmented/virtual reality, and robotics. Our goal is to significantly improve patient outcomes and surgeon wellbeing through the collaboration of physician expertise and immersive, intelligent technology. We work closely with industry-leading medical and technical advisors and reputable research institutions specializing in neurosurgery, medical devices, AI, computer vision, and robotics to dimensionalize and digitize surgical vision in groundbreaking, real-time applications. A quickly-growing, award-winning company, our team consists of creative, diverse, multi-disciplinary thinkers and innovators who value designing technology for positive and unprecedented social and industry impact.
Location: United States
Employees: 11-50
Total raised: $66M
Founded date: 2016
Investors 6
| Date | Name | Website |
| - | Bold Capit... | boldcapita... |
| - | DCVC | dcvc.com/ |
| - | East Seatt... | eastseattl... |
| - | Intel Capi... | intel.com |
| - | The Ventur... | thevrfund.... |
| 18.06.2020 | Cota Capit... | cotacapita... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 31.07.2023 | Series B | $43M | - |
| 17.06.2020 | Series A | $23M | - |
Mentions in press and media 24
| Date | Title | Description |
| 02.06.2026 | Carecubes Names Kabir Gulati CEO as Company Accelerates National Expansion USA - English | Healthcare technology veteran joins on the heels of $6.5M Series A and adoption across 47 communities and 15 states; founder Alex Laskey transitions to Executive Chairman. ARLINGTON, Va., June 2, 2026 /PRNewswire-PRWeb/ -- Carecubes, which ... |
| 16.01.2026 | Proprio Secures 4th FDA Clearance for AI-Powered ‘Picasso’ Spine Guidance | What You Should Know: – Proprio has secured FDA clearance for Picasso, its fourth cleared capability within the Paradigm AI surgical platform. – The feature enables “trace-based” optical registration, allowing spine surgeons to perform real... |
| 13.01.2025 | Proprio Partners with LifeHealthcare to Expand Global Access to First AI Surgical Guidance System | Collaboration to Launch in Australia and New Zealand, with Plans to Broaden Access to Proprio’s AI Guidance Platform, Paradigm, to Address Global Unmet Medical Needs Proprio, the global leader in AI-powered surgical technology, today announ... |
| 17.09.2024 | Navigating the Complex Landscape of Healthcare Technology: A Dual Focus on User Experience and Patient Safety | In the realm of healthcare, technology is a double-edged sword. On one side, it promises to enhance patient outcomes and streamline workflows. On the other, it poses risks if not designed with care. The challenge lies in balancing user expe... |
| 12.09.2024 | Balancing User Experience and Technical Complexity in Surgical Software Design | Neeraj Mainkar, VP of Software Engineering & Advanced Technology at Proprio In healthcare, the impact of well-designed medical devices reaches far beyond their physical form. When these devices are thoughtfully crafted with the end-user... |
| 19.01.2024 | Shifting the Paradigm: Data-Driven Product Development and the AI-Driven Standard of Care | Tommy Carls, VP of Product Development & Marketing at Proprio Over the past decade, product development has undergone a transformative shift, driven by the integration of AI, machine learning, and data-driven approaches. Traditional met... |
| 17.10.2023 | Proprio Announces Completion of World’s First Light Field-Enabled Spine Surgery Using Its AI-Driven Technology Platform, Paradigm | Breakthrough technology revolutionizes how hospitals and surgeons provide care and pioneers a generational shift to data-driven value across the healthcare ecosystem Proprio, a Seattle-based medical technology company, announced the success... |
| 31.07.2023 | Seattle-based surgical tech startup Proprio raises USD 43 million in Series B funding | 27 July 2023, Seattle A surgical technology firm called Proprio in Seattle has revealed that it has received USD 43 million in Series B funding from both new and existing investors. The funding supports commercialization to meet Proprio’s A... |
| 28.07.2023 | Proprio raises $43M to commercialize surgical navigation platform | Photo: Caiaimage/Sam Edwards/Getty Images |
| 27.07.2023 | Proprio Scoops Up $43M Series B Funding | SEATTLE, WA, Proprio, a surgical technology company, today announced that it has secured $43 million in Series B funding from new and existing investors. >> Click here for more funding data on Proprio >> To export Proprio fu... |
Show more